finster 5 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - finasterīds - apvalkotā tablete - 5 mg
qtrilmet
astrazeneca ab - metformīns hidrohlorīds, saxagliptin, dapagliflozin - cukura diabēts, 2. tips - cukura diabēts - qtrilmet ir norādīts pieaugušajiem vecumā no 18 gadiem un vecāki ar 2. tipa cukura diabētu:lai uzlabotu glycaemic kontroles, ja metformīns ar vai bez sulfonilurīnvielas pamata (su) un vai nu saxagliptin vai dapagliflozin nenodrošina pietiekamu kontroles glycaemic. ja jau tiek ārstēti ar metformīnu un saxagliptin un dapagliflozin.
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - multiple mieloma - antineoplastiski līdzekļi - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
empagliflozin polpharma 10 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - empagliflozīns - apvalkotā tablete - 10 mg
empagliflozin polpharma 25 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - empagliflozīns - apvalkotā tablete - 25 mg
glusod 10 mg apvalkotās tabletes
medochemie ltd., cyprus - empagliflozīns - apvalkotā tablete - 10 mg
glusod 25 mg apvalkotās tabletes
medochemie ltd., cyprus - empagliflozīns - apvalkotā tablete - 25 mg